Abedelmajeed Nasereddin

Dr. Abedelmajeed Nasereddin


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2025 in Cureus
Verified
Journal Article
Open access
SESuheir Ereqat
Suheir Ereqat
MSMaha Sharabati
Maha Sharabati
MAMayar Abuhilal
Mayar Abuhilal
ANAbedelmajeed Nasereddin
Abedelmajeed Nasereddin

20 June 2024 in Pathogens
Verified
Journal Article
Open access
PDF file
SESuheir Ereqat
Suheir Ereqat
NANabil-Fareed Alikhan
Nabil-Fareed Alikhan
AAAmer Al-Jawabreh
Amer Al-Jawabreh
MMMichaela Matthews
Michaela Matthews
Ahmed Al-JawabrehAhmed Al-Jawabreh
Ahmed Al-Jawabreh
ANAbedelmajeed Nasereddin
Abedelmajeed Nasereddin
The emergence of new SARS-CoV-2 variants in Palestine highlights the need for continuous genetic surveillance and accurate screening strategies. This case series study aimed to investigate the geographic distribution and genetic variation of the SARS-CoV-2 Delta Variant in Palestine in August 2021. Samples were collected at random in August 2021 (n = 571) from eight districts in the West Bank, Palestine. All samples were confirmed as positive for COVID-19 by RT-PCR. The samples passed the quality control test and were successfully sequenced using the ARTIC protocol. The Delta Variant was revealed to have four dominant lineages: B.1.617 (19%), AY.122 (18%), AY.106 (17%), and AY.121 (13%). The study revealed eight significant purely spatial clusters (p < 0.005) distributed in the northern and southern parts of Palestine. Phylogenetic analysis of SARS-CoV-2 genomes (n = 552) showed no geographically specific clades. The haplotype network revealed three haplogroups without any geographic distribution. Chronologically, the Delta Variant peak in Palestine was shortly preceded by the one in the neighboring Israeli community and shortly followed by the peak in Jordan. In addition, the study revealed an extremely intense transmission network of the Delta Variant circulating between the Palestinian districts as hubs (SHR ≈ 0.5), with Al-Khalil, the district with the highest prevalence of COVID-19, witnessing the highest frequency of transitions. Genetic diversity analysis indicated closely related haplogroups, as haplotype diversity (Hd) is high but has low nucleotide diversity (π). However, nucleotide diversity (π) in Palestine is still higher than the global figures. Neutrality tests were significantly (p < 0.05) low, including Tajima’s D, Fu-Li’s F, and Fu-Li’s D, suggesting one or more of the following: population expansion, selective sweep, and natural negative selection. Wright’s F-statistic (Fst) showed genetic differentiation (Fst > 0.25) with low to medium gene flow (Nm). Recombination events were minimal between clusters (Rm) and between adjacent sites (Rs). The study confirms the utility of the whole genome sequence as a surveillance system to track the emergence of new SARS-CoV-2 variants for any possible geographical association and the use of genetic variation analysis and haplotype networking to delineate any minimal change or slight deviation in the viral genome from a reference strain.

4 February 2026 in Scientific Reports
Verified
Journal Article
Open access
PDF file
BSBisan Safi
Bisan Safi
MKMahmoud Khalid
Mahmoud Khalid
ANAbedelmajeed Nasereddin
Abedelmajeed Nasereddin
Oral human papillomavirus (HPV) is a key contributor to oropharyngeal cancers. Yet, its prevalence and genotype distribution in healthy populations remain largely undocumented, particularly in Palestine, where no national screening or vaccination programs currently exist. This study is the first in Palestine to detect and genotype oral HPV in a healthy population using a highly sensitive molecular workflow. The assay employs a nested polymerase chain reaction (PCR) and next-generation sequencing (NGS) strategy targeting the L1 gene, a highly conserved region that encodes the virus’s main structural protein. Buccal swabs from 75 individuals attending dental clinics in the central region of the West Bank were analyzed, revealing an overall HPV positivity rate of 6.7% and identifying the genotypes HPV-18, HPV-31, and HPV-38. Recently, an HPV-38 sequence from a Palestinian woman with cervical cancer was published, which supports our finding of HPV-38 presence in Palestine. The results provide preliminary methodological data for Palestine and highlight the power of advanced sequencing technologies in enhancing global HPV surveillance. This pilot study demonstrates methodological feasibility but is not powered to provide a reliable epidemiological baseline.